• Education
  • |
  • Points
  • Get the app
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
Home Find Drugs Pill Identifier Find Drug Company Diseases Medical News & Updates
Other Services
MIMS Education MIMS Points Download App
Country
  • a globesingapore
  • a globehong kong
  • a globeindonesia
  • a globethailand
  • a globephilippines
  • a globevietnam
  • a globeindia
  • a globeaustralia
  • a globekorea
  • a globenew zealand
The MIMS logo.
  1. Home icon
  2. Medical News & Updates
    • Medical News & Updates
  3. List of News & Updates

News & Updates

Search

Showing Dermatology articles

Showing

MultidisciplinaryCardiologyDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
MultidisciplinaryCardiologyDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy

Filters

Specialty:

MultidisciplinaryCardiologyDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
Show Multimedia Only
Possible allergic reaction should not delay COVID-19 vaccination

Possible allergic reaction should not delay COVID-19 vaccination

10 Nov 2021 byPearl Toh
Pearl Toh

People who had an allergic response to the first dose of COVID-19 vaccination or who believe they will have an allergy to vaccination should not let their worries delay getting vaccinated — as most of them can still be fully vaccinated safely, suggest studies presented at ACAAI 2021.

10 Nov 2021
Ruxolitinib cream improves repigmentation in patients with vitiligo

Ruxolitinib cream improves repigmentation in patients with vitiligo

09 Nov 2021 byElaine Soliven
Elaine Soliven

The application of ruxolitinib cream led to significant improvements in facial and total body repigmentation among adolescents and adults with vitiligo, according to two phase III studies presented at EADV 2021.

09 Nov 2021
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
The MIMS logo.
  • Drugs
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • MIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Editorial Advisory Board
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Points
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with MIMS
A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
MIMS Specialty feature/MSP-2132-ai-disease-summary-squashed_3201.1
Copyright © 2026 MIMS Pte Ltd. All rights reserved. SIT
MIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.